Race and ethnicity reporting for clinical trials in ClinicalTrials.gov and publications

Inclusion and subsequent reporting of minority participants in clinical trials are critical for ensuring external validity and detecting differences among subgroups, however reports suggest that ongoing gaps persist. ClinicalTrials.gov began requiring the reporting of race/ethnicity information (if collected) during results submission for trials in April 2017. For this study, we downloaded and compared trial race/ethnicity information from ClinicalTrials.gov submitted before (N  = 3540) and after (N = 3542) the requirement date.

Source: Contemporary Clinical Trials - December 5, 2020 Category: Radiology Authors: Kevin M. Fain, Julianne Nelson, Tony Tse, Rebecca J. Williams Tags: Short Communication Source Type: research